Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial

Narek Shaverdian, Aaron Elliott Lisberg, Krikor Bornazyan et al. · The Lancet Oncology · 2017

Cited by 1,089 works. doi:10.1016/s1470-2045(17)30380-7

Authors

References